Trilogy^® Pretreatment Solution

Trilogy^® Pretreatment Solution is intended to be used for immunohistochemical assays on formalin-fixed, paraffin-embedded (FFPE) tissue sections. Using this product eliminates the need for multiple solutions to deparaffinize, rehydrate, and antigen retrieve FFPE tissue samples.¹ The use of a single solution allows for a standardized pretreatment protocol that produces consistent and reliable results when used in conjunction with Cell Marque Primary Antibodies.

1. Aghassi et al. (2003). Composition and Method for Treating Tissue Samples (U.S. Patent No. 6,649,368). U.S. Patent and Trademark Office. https://rb.gy/gy42ef

We are committed to bringing you greener alternative products, which adhere to one or more of The 12 Principles of Green Chemistry. This product is an environmentally-friendly, non-toxic alternative and eliminates the need for xylene when working with paraffin-embedded tissue, and thus aligns with "Waste Prevention", and ″Designing Safer Chemicals″. Click here for more information.

Note: This product is similar in use to Trilogy^® Pretreatment Solution (920P series products) but does not contain IGEPAL^® CA-630 and complies with European Union (EU) Regulation (EC) No 1907/2006, REACH.

Solution containing pretreatment reagents.

Download the IFU specific to your product lot and format
Note: This requires a keycode which can be found on your packaging or product label.

For Technical Service please contact: 800-665-7284 or email: service@cellmarque.com

IGEPAL is a registered trademark of Solvay

Trilogy is a registered trademark of Merck KGaA, Darmstadt, Germany